States Struggle With Vaccine Pause as Federal Officials Reassure Public
Sheryl Gay Stolberg et al., The New York Times
Dr. Anthony S. Fauci said he hoped for a decision “quite soon” on the Johnson & Johnson vaccine, as local governments shifted to more complicated two-dose vaccines for marginal populations.
Blood Clots More Likely After Covid-19 Than After Vaccination, Study Finds
Jenny Strasburg, The Wall Street Journal
A study by the University of Oxford found the risk of rare but sometimes-deadly blood clotting is roughly eight to 10 times greater in Covid-19 sufferers than among people who have received any of the first three Western-developed vaccines widely available.
CDC: About 5,800 ‘breakthrough infections’ reported in fully vaccinated people
Erika Edwards, NBC News
On Thursday morning, the CDC said it had reports of approximately 5,800 so-called breakthrough infections, out of the nearly 77 million individuals in the United States who have been fully vaccinated.
Unused Vaccines Are Piling Up Across U.S. as Some Regions Resist
Anna Edney and Drew Armstrong, Bloomberg
Many U.S. states and cities have a growing surplus of Covid-19 vaccines, a sign that in some places demand is slowing before a large percentage of the population has been inoculated, according to an analysis by Bloomberg News.
Vaccines Won’t Protect Millions of Patients With Weakened Immune Systems
Apoorva Mandavilli, The New York Times
Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.
Lilly asks FDA to revoke authorization for COVID-19 antibody bamlanivimab alone
Manojna Maddipatla, Reuters
Eli Lilly and Co said on Friday it had requested the U.S. Food and Drug Administration to revoke the emergency use authorization granted to its COVID-19 antibody bamlanivimab alone due to the full availability of its combination therapy.
Next-generation Covid-19 vaccines are supposed to be better. Some experts worry they could be worse
Helen Branswell, Stat News
With Covid-19 vaccines, the world hopes to beat back the virus that causes the disease. But some scientists are increasingly concerned that, because of a quirk of our own biology, future iterations of the vaccines might not always be quite as effective as they are today.
The Covax initiative seeks $2 billion to lock up vaccine in advance for lower-income countries.
Sheri Fink, The New York Times
An effort to promote Covid-19 vaccination in the world’s lowest-income countries is trying to raise an additional $2 billion to help secure access to doses before they are snapped up by wealthier nations.
Indian vaccine maker asks US to ease export curbs
Aniruddha Ghosal, The Associated Press
The chief executive of Serum Institute of India, the world’s largest maker of vaccines and a critical supplier of the U.N.-backed COVAX facility, asked President Joe Biden on Twitter to lift the U.S. embargo on exporting raw materials needed to make the the jabs.
Around the World, Conflicting COVID-19 Vaccination Advice Puts Pregnant People At Risk
Jessica Abrahams, The Fuller Project
Pregnant and lactating people have been excluded from clinical trials for all the major COVID-19 vaccines. The lack of data has led to ambiguous and sometimes conflicting guidance from health authorities around the world.
